Finance
Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit
COPENHAGEN, March 9 (Reuters) - Novo Nordisk has agreed to sell its blockbuster Wegovy and Ozempic d...
9th March, 2026
Pharmaceuticals
Finance
Roche shares drop as oral breast cancer drug fails in trial
FRANKFURT, March 9 (Reuters) - Shares in Roche dropped more than 5% on Monday as the Swiss drugmaker...
9th March, 2026
Finance
GSK licenses liver disease drug to Italy's Alfasigma for up to $690 million
March 9 (Reuters) - GSK said on Monday it will receive up to $690 million from Italian pharmaceutica...
9th March, 2026
Finance
Galderma gives better than expected 2026 guidance, shares rise
March 5 (Reuters) - Shares of Swiss skincare company Galderma opened higher on Thursday after it rep...
5th March, 2026
Finance
Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 billion
March 4 (Reuters) - Hong Kong-listed Sino Biopharmaceutical said on Wednesday its unit has signed an...
3rd March, 2026
Finance
Hims' pharmacy partner will reintroduce GLP-1 pill pulled from market, Endpoints News reports
March 3 (Reuters) - Hims & Hers Health's pharmacy partner, Strive Pharmacy, plans to resume sales of...
3rd March, 2026
Finance
Roche targets double-digit market share in weight loss, aims to catch up with Novo Nordisk, Handelsblatt reports
BERLIN, March 3 (Reuters) - Swiss pharmaceutical company Roche is aiming for a double-digit market s...
3rd March, 2026
Finance
EU regulator backs approval for Moderna's combined COVID and flu vaccine
By Bhanvi Satija Feb 27 (Reuters) - Europe's medicines regulator recommended approval for Moderna's...
27th February, 2026
Finance
Drugmaker Rovi's net profit rises on higher Okedi, heparin sales
Feb 25 (Reuters) - Spanish drugmaker Laboratorios Farmaceuticos Rovi said on Wednesday its 2025 net...
25th February, 2026